Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is, once again, maple cinnamon French toast. Remember that no prescription is required — so no co-pay or rebate is involved. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. …
President Biden on Wednesday will tout Democrat efforts to lower the cost of inhalers after drugmakers announced plans to cap prices, The Hill writes. The president, alongside U.S. Sen. Bernie Sanders (I-Vt.), will give remarks at the White House to highlight the action on the cost of inhalers. They will also be joined by health care advocates and experts, according to a White House official. After the administration’s crackdown, which included scrutiny for anticompetitive practices that can delay lower-cost generics from coming to market, three of the four largest inhaler manufacturers announced in March that they would cap the cost of inhalers for many patients at $35 per month.
The White House at long last published a plan to stem drug shortages, and it involves basing Government-run Medicare pay to hospitals on whether they adopt business practices that avoid shortages, STAT writes. The plan would create two nongovernmental organizations that the government would accredit — one would rate drugmakers on how well they maintain resilient supply chains and the other would rate hospitals on their performance. The government’s Manufacturing Resiliency Assessment Program would create metrics and a process to assess drugmaker practices to monitor for shortages and improve manufacturing performance.
Click this link for the original source of this article.
Author: Ed Silverman
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.